Phathom Pharmaceuticals, Inc. — Director's Dealing 2023

Jun 6, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Phathom Pharmaceuticals, Inc. (PHAT)
CIK: 0001783183
Period of Report: 2023-06-02

Reporting Person: Parikh Asit (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-06-02	Common Stock	A	15000	$7.40	Acquired	47500	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-06-02	Stock Option (Right to Buy)	$7.40	D	15000	Disposed	2032-05-24	Common Stock (15000)	Direct

Footnotes

F1: The option was granted pursuant to the Issuer's Non-Employee Director Compensation Program and vested/became exercisable on the first anniversary of the date of grant.